Does ALIROCUMAB Cause Nasopharyngitis? 557 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 557 reports of Nasopharyngitis have been filed in association with ALIROCUMAB (Praluent). This represents 2.4% of all adverse event reports for ALIROCUMAB.
557
Reports of Nasopharyngitis with ALIROCUMAB
2.4%
of all ALIROCUMAB reports
0
Deaths
26
Hospitalizations
How Dangerous Is Nasopharyngitis From ALIROCUMAB?
Of the 557 reports, 26 (4.7%) required hospitalization.
Is Nasopharyngitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 557 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which ALIROCUMAB Alternatives Have Lower Nasopharyngitis Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN